You are viewing: Rest Of Asia Pacific Theranostics Market analysis
Part of: Theranostics Market (Global)

The Rest Of Asia Pacific Theranostics Market was valued at $16.1 Million in 2023 and projected to reach to $25.6 Million by 2028, representing a compound annual growth rate of 9.7%. The Rest Of Asia Pacific theranostics market is positioned for sustained growth through 2028, driven by increasing healthcare expenditures and growing demand for integrated diagnostic-therapeutic solutions.

Rest Of Asia Pacific Theranostics Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Asia Pacific Theranostics Market Trends and Insights

  • Rest Of Asia Pacific represents a significant emerging opportunity within the broader Asia Pacific region, driven by increasing healthcare investments and rising adoption of precision medicine technologies.
  • The region's growth trajectory reflects expanding diagnostic and therapeutic capabilities across multiple countries. Rest Of Asia Pacific's theranostics market is characterized by growing demand for integrated diagnostic-therapeutic solutions that improve patient outcomes and reduce treatment costs.
  • Between 2023 and 2028, Rest Of Asia Pacific is expected to capture increasing market share as healthcare infrastructure modernizes and awareness of theranostic applications spreads.
  • The 9.7% compound annual growth rate underscores Rest Of Asia Pacific's potential as a high-growth market segment within the global theranostics landscape..

Key Market Statistics

  • CAGR (2023-2028) 9.7% CAGR
  • Market Size, 2023 ~USD 16.1 Million
  • Forecast, 2028 ~USD 25.6 Million
  • Country Rest Of Asia Pacific

Rest Of Asia Pacific Theranostics Market Overview

Steady Regional Growth :

Rest Of Asia Pacific theranostics market valued at $16.1 million in 2023, with projected growth to $25.6 million by 2028, representing a robust 9.7% CAGR driven by emerging healthcare infrastructure.

Precision Medicine Adoption :

Rising adoption of precision medicine technologies across Rest Of Asia Pacific countries is accelerating theranostics integration, supported by increasing awareness among healthcare providers and patients.

Healthcare Investment Surge :

Significant healthcare investments in Rest Of Asia Pacific nations are creating favorable conditions for theranostics market expansion, with governments prioritizing advanced diagnostic and therapeutic solutions.

Emerging Market Opportunity :

Rest Of Asia Pacific represents a significant emerging opportunity within the broader Asia Pacific region, with untapped potential for market penetration and technology adoption in developing healthcare systems.

Rest Of Asia Pacific Theranostics Market Dynamics

  • Countries in this region are progressively adopting precision medicine frameworks, supported by improving healthcare infrastructure and rising patient awareness of advanced treatment options.
  • The 9.7% CAGR reflects steady market maturation as healthcare providers recognize the clinical and economic benefits of theranostics.
  • Government initiatives promoting healthcare modernization and private sector investments are expected to further accelerate market expansion.
  • However, challenges including regulatory variations, limited reimbursement frameworks, and healthcare resource constraints may moderate growth rates compared to developed Asia Pacific markets, requiring tailored market strategies for individual country contexts..

Related Ecosystem

Pharmaceuticals

Top Technologies
  • Bioreactors
  • Analytical Testing
  • Bioanalytical Testing Services
  • Cell Counters
  • Data Management Services
Top Companies
  • Thermo Fisher Scientific Inc.
  • SANOFI
  • Merck KGaA
  • NOVARTIS
  • Pfizer Inc.

    Key Takeaways

    • Rest Of Asia Pacific theranostics market valued at $16.1 million in 2023, expanding to $25.6 million by 2028
    • Rest Of Asia Pacific demonstrates a 9.7% CAGR, reflecting strong regional demand for precision diagnostic-therapeutic solutions
    • Rest Of Asia Pacific's growth is driven by healthcare modernization and increased adoption of integrated theranostic platforms
    • Rest Of Asia Pacific represents an emerging high-growth opportunity within the broader Asia Pacific theranostics landscape

    Theranostics Market Report Scope

    Report Metric Details
    Base Year 2023
    Fastest Growing Segment THERANOSTICS CENTERS (End User)
    Forecast Period 2023-2028
    Growth Rate CAGR of 15.5% from 2023 to 2028
    Largest Segment RADIOPHARMACEUTICALS (Product)
    Market Size Base Year (Billions) ~USD 2.09 (2023)
    Revenue Forecast (Billions) ~USD 4.3 (2028)
    Segments Covered Product, Type, Application, End User

    Rest Of Asia Pacific Theranostics Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Diagnostic Imaging
    • Ivd/Biomarker Screening
    • Radiopharmaceuticals
    • Software & Services

    By Type

    • Iodine-131
    • Lutetium-177
    • Other Radiopharmaceuticals
    • Radium-223
    • Samarium-153
    • Yttrium-90

    By Application

    • Bone Metastasis
    • Other Applications
    • Other Cancer
    • Other Cancers
    • Prostate Cancer

    By End User

    • Hospitals And Cancer Care Centers
    • Research And Academic Centers
    • Theranostics Centers

    Target Audience

    • Theranostics Device Manufacturers : Require detailed Rest Of Asia Pacific market sizing and growth forecasts to prioritize regional expansion, allocate R&D resources, and develop localized product strategies for emerging markets.
    • Healthcare Investment Firms : Need region-specific market analysis to identify investment opportunities, assess growth potential, and evaluate portfolio companies' expansion prospects in Rest Of Asia Pacific theranostics sector.
    • Pharmaceutical Companies : Seek granular Rest Of Asia Pacific data to guide precision medicine portfolio development, partnership strategies, and market entry decisions in this emerging therapeutic segment.
    • Healthcare Consultants : Utilize Rest Of Asia Pacific-specific insights to advise clients on market opportunities, competitive positioning, and strategic recommendations for theranostics business development.
    • Government & Healthcare Policy Makers : Use regional market intelligence to inform healthcare infrastructure investments, precision medicine policy frameworks, and technology adoption initiatives specific to Rest Of Asia Pacific countries.

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights specific to Rest Of Asia Pacific rather than broad Asia Pacific data, enabling precise market positioning and localized strategy development for this emerging region.
    • Growth Trajectory Analysis : Understand the 9.7% CAGR dynamics and $9.5 million market expansion opportunity from 2023-2028, identifying optimal entry points and investment timing for regional expansion.
    • Competitive Landscape Intelligence : Access region-specific competitive dynamics, market barriers, and opportunity gaps unique to Rest Of Asia Pacific countries, differentiating from global market trends.
    • Investment Decision Support : Make informed capital allocation decisions with quantified market size, growth projections, and emerging opportunity assessment tailored to Rest Of Asia Pacific market conditions.
    • Strategic Market Entry Planning : Develop targeted go-to-market strategies leveraging region-specific healthcare investment trends, regulatory environments, and precision medicine adoption patterns in Rest Of Asia Pacific.

    Frequently asked questions

    What is the current market size of theranostics in Rest Of Asia Pacific?

    Rest Of Asia Pacific's theranostics market was valued at $16.1 million in 2023 and is projected to reach $25.6 million by 2028.

    What is the expected growth rate for Rest Of Asia Pacific theranostics market?

    Rest Of Asia Pacific theranostics market is expected to grow at a compound annual growth rate (CAGR) of 9.7% from 2023 to 2028.

    What factors are driving growth in Rest Of Asia Pacific theranostics market?

    Rest Of Asia Pacific's theranostics market growth is driven by healthcare infrastructure modernization, increased precision medicine adoption, and rising awareness of integrated diagnostic-therapeutic solutions.

    How does Rest Of Asia Pacific compare to other Asia Pacific regions?

    Rest Of Asia Pacific represents an emerging segment within Asia Pacific with distinct growth dynamics, characterized by expanding healthcare investments and growing demand for theranostic applications.

    What is the forecast market size for Rest Of Asia Pacific theranostics by 2028?

    Rest Of Asia Pacific theranostics market is forecasted to reach $25.6 million by 2028, representing a 59% increase from the 2023 baseline of $16.1 million.

    RESEARCH METHODOLOGY

    The study involved four major activities in estimating the current size of the theranostics market. Exhaustive secondary research was done to collect information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

    Secondary Research

    The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial theranostics market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as OEMs, CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations in the theranostics market. The primary sources from the demand side include medical CDMOs, oncologists, doctors, radiologists, technicians, and service providers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.

    A breakdown of the primary respondents is provided below:

    Theranostics Market Size, and Share

    *Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

    Note: Companies are classified into tiers based on their total revenue. As of 2021, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Estimation Methodology

    In this report, the theranostics market’s size was determined using the revenue share analysis of leading players. For this purpose, key players in the market were identified, and their revenues from the market business were determined through various insigh ts gathered during the primary and secondary research phases. Secondary research included the study of the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, such as CEOs, directors, and key marketing executives.

    Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:

    • Generating a list of major global players operating in the theranostics market.
    • Mapping annual revenues generated by major global players from the product segment (or nearest reported business unit/category)
    • Revenue mapping of major players to cover a major share of the global market share, as of 2022
    • Extrapolating the global value of the theranostics market industry

    Theranostics Market Size, and Share

    Data Triangulation

    After arriving at the overall market size from the market size estimation process explained above, the global theranostics market was split into segments and subsegments. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the market was validated using top-down and bottom-up approaches.

    Market Definition

    Theranostics is a term used for diagnosis and therapy. Theranostics can be broadly defined as a combination of molecularly targeted imaging and therapy, whereas imaging helps to gain information regarding presence of targeted moleculaes on cell surface and therapy progression. Radiotheranostics involves the use of radionuclide/radiopharmaceutical that delivers targeted radiation to kill the cancerous cells and imaging modality such as positron emission tomography (PET) is used to locate the cancer.  FDA approved theranostics procedures are performed for different applications such as prostate cancer, neuroendocrine tumor, etc. These procedures are mainly performed in hospitals, cancer care centers, and  theranostics centers.

    Key Stakeholders

    • Senior Management
    • End Users
    • R&D Department
    • Finance/Procurement Department

    Objectives of the Study

    • To define, describe, and forecast the size of theranostics market based on product, application, end user, and region
    • To provide detailed information regarding the major factors influencing the growth potential of the global market (drivers, restraints, opportunities, challenges, and trends)  
    • To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global market.   
    • To analyze key growth opportunities in the global market for key stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of market segments and/or subsegments with respect to three major regions, namely, North America (US and Canada), Europe (Germany, France, the UK, and the RoE), Asia Pacific (Japan, China, India, and the RoAPAC), and Rest of the World (Latin America and Middle East and Africa).
    • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
    • To track and analyze the competitive developments undertaken in the global market, such as product launches; agreements; expansions; and mergers & acquisitions.

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for the present global theranostics market report:

    Product Analysis

    • Product matrix, which gives a detailed comparison of the product portfolios of the top fifteen companies

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographic Analysis

    • Further breakdown of the Rest of Europe theranostics market into Italy, Spain Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
    • Further breakdown of the Rest of Asia Pacific theranostics market into Australia, South Korea, Singapore, Taiwan, New Zealand, Philippines, Malaysia, and other APAC countries

    Get the Full Theranostics Market Report

    Full forecast, segment splits, and company analysis for all Theranostics Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status